A citation-based method for searching scientific literature

Yuqian Bao, Li Chen, Liming Chen, Jingtao Dou, Zhengnan Gao, Leili Gao, Lixin Guo, Xiaohui Guo, Linong Ji, Qiuhe Ji, Weiping Jia, Hongyu Kuang, Qifu Li, Qiang Li, Xiaoying Li, Yanbing Li, Ling Li, Jing Liu, Jianhua Ma, Xingwu Ran, Lixin Shi, Guangyao Song, Yufei Wang, Jianping Weng, Xinhua Xiao, Yun Xie, Guangxia Xi, Liyong Yang, Zhigang Zhao, Jian Zhou, Zhiguang Zhou, Dalong Zhu, Dajin Zou. Diabetes Metab Res Rev 2019
Times Cited: 4







List of co-cited articles
3 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range.
Tadej Battelino, Thomas Danne, Richard M Bergenstal, Stephanie A Amiel, Roy Beck, Torben Biester, Emanuele Bosi, Bruce A Buckingham, William T Cefalu, Kelly L Close,[...]. Diabetes Care 2019
618
50

Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes.
Louis Monnier, Emilie Mas, Christine Ginet, Françoise Michel, Laetitia Villon, Jean-Paul Cristol, Claude Colette. JAMA 2006
50

International Consensus on Use of Continuous Glucose Monitoring.
Thomas Danne, Revital Nimri, Tadej Battelino, Richard M Bergenstal, Kelly L Close, J Hans DeVries, Satish Garg, Lutz Heinemann, Irl Hirsch, Stephanie A Amiel,[...]. Diabetes Care 2017
599
50


Toward Defining the Threshold Between Low and High Glucose Variability in Diabetes.
Louis Monnier, Claude Colette, Anne Wojtusciszyn, Sylvie Dejager, Eric Renard, Nicolas Molinari, David R Owens. Diabetes Care 2017
130
25


Glargine insulin/gliclazide MR combination therapy is more effective than premixed insulin monotherapy in Chinese patients with type 2 diabetes inadequately controlled on oral antidiabetic drugs.
Jian Zhou, Fenping Zheng, Xiaohui Guo, Huazhang Yang, Muxun Zhang, Haoming Tian, Lixin Guo, Qiang Li, Yifei Mo, Weiping Jia. Diabetes Metab Res Rev 2015
9
25

Acarbose: safe and effective for lowering postprandial hyperglycaemia and improving cardiovascular outcomes.
James J DiNicolantonio, Jaikrit Bhutani, James H O'Keefe. Open Heart 2015
50
25

Acarbose reduces the risk for myocardial infarction in type 2 diabetic patients: meta-analysis of seven long-term studies.
M Hanefeld, M Cagatay, T Petrowitsch, D Neuser, D Petzinna, M Rupp. Eur Heart J 2004
454
25

Glycemic variability is higher in type 1 diabetes patients with microvascular complications irrespective of glycemic control.
Jan Šoupal, Jan Škrha, Martin Fajmon, Eva Horová, Miloš Mráz, Jan Škrha, Martin Prázný. Diabetes Technol Ther 2014
58
25

Glycemic Variability: How Do We Measure It and Why Is It Important?
Sunghwan Suh, Jae Hyeon Kim. Diabetes Metab J 2015
147
25



Glucose Outcomes with the In-Home Use of a Hybrid Closed-Loop Insulin Delivery System in Adolescents and Adults with Type 1 Diabetes.
Satish K Garg, Stuart A Weinzimer, William V Tamborlane, Bruce A Buckingham, Bruce W Bode, Timothy S Bailey, Ronald L Brazg, Jacob Ilany, Robert H Slover, Stacey M Anderson,[...]. Diabetes Technol Ther 2017
253
25


Comparison of the effects of acarbose and metformin use on ovulation rates in clomiphene citrate-resistant polycystic ovary syndrome.
A S Sönmez, L Yasar, K Savan, S Koç, J Ozcan, A Toklar, F Yazicioğu, A Akgün, N Sut. Hum Reprod 2005
23
25

Variation in 125I-insulin absorption and blood glucose concentration.
T Lauritzen, O K Faber, C Binder. Diabetologia 1979
123
25


Evaluation of efficacy of acarbose on glucose fluctuation and postprandial glucose using continuous glucose monitoring in type 2 diabetes mellitus.
Yutaka Mori, Masatsugu Shiozaki, Kenichi Matsuura, Takaaki Tanaka, Junichi Yokoyama, Kazunori Utsunomiya. Diabetes Technol Ther 2011
11
25

Acarbose compared with metformin as initial therapy in patients with newly diagnosed type 2 diabetes: an open-label, non-inferiority randomised trial.
Wenying Yang, Jie Liu, Zhongyan Shan, Haoming Tian, Zhiguang Zhou, Qiuhe Ji, Jianping Weng, Weiping Jia, Juming Lu, Jing Liu,[...]. Lancet Diabetes Endocrinol 2014
88
25

Association of glycemic variability and the presence and severity of coronary artery disease in patients with type 2 diabetes.
Gong Su, Shuhua Mi, Hong Tao, Zhao Li, Hongxia Yang, Hong Zheng, Yun Zhou, Changsheng Ma. Cardiovasc Diabetol 2011
158
25


Validation of Time in Range as an Outcome Measure for Diabetes Clinical Trials.
Roy W Beck, Richard M Bergenstal, Tonya D Riddlesworth, Craig Kollman, Zhaomian Li, Adam S Brown, Kelly L Close. Diabetes Care 2019
203
25

Association between 7 years of intensive treatment of type 1 diabetes and long-term mortality.
Trevor J Orchard, David M Nathan, Bernard Zinman, Patricia Cleary, David Brillon, Jye-Yu C Backlund, John M Lachin. JAMA 2015
251
25


Assessment of the association between glycemic variability and diabetes-related complications in type 1 and type 2 diabetes.
J Smith-Palmer, M Brändle, R Trevisan, M Orsini Federici, S Liabat, W Valentine. Diabetes Res Clin Pract 2014
100
25


Mean amplitude of glycemic excursions, a measure of diabetic instability.
F J Service, G D Molnar, J W Rosevear, E Ackerman, L C Gatewood, W F Taylor. Diabetes 1970
826
25


Glycemic variability in continuous glucose monitoring is inversely associated with baroreflex sensitivity in type 2 diabetes: a preliminary report.
Daisuke Matsutani, Masaya Sakamoto, Hiroyuki Iuchi, Souichirou Minato, Hirofumi Suzuki, Yosuke Kayama, Norihiko Takeda, Ryuzo Horiuchi, Kazunori Utsunomiya. Cardiovasc Diabetol 2018
21
25

Oscillating glucose is more deleterious to endothelial function and oxidative stress than mean glucose in normal and type 2 diabetic patients.
Antonio Ceriello, Katherine Esposito, Ludovica Piconi, Michael A Ihnat, Jessica E Thorpe, Roberto Testa, Massimo Boemi, Dario Giugliano. Diabetes 2008
699
25

An importance of carbohydrate ingestion for the expression of the effect of alpha-glucosidase inhibitor in NIDDM.
T Hara, J Nakamura, N Koh, F Sakakibara, N Takeuchi, N Hotta. Diabetes Care 1996
42
25

Association of Time in Range, as Assessed by Continuous Glucose Monitoring, With Diabetic Retinopathy in Type 2 Diabetes.
Jingyi Lu, Xiaojing Ma, Jian Zhou, Lei Zhang, Yifei Mo, Lingwen Ying, Wei Lu, Wei Zhu, Yuqian Bao, Robert A Vigersky,[...]. Diabetes Care 2018
144
25

Glucose variability, HbA1c and microvascular complications.
Jan Škrha, Jan Šoupal, Jan Škrha, Martin Prázný. Rev Endocr Metab Disord 2016
52
25

The mechanisms of action of metformin.
Graham Rena, D Grahame Hardie, Ewan R Pearson. Diabetologia 2017
605
25

Prevalence and Ethnic Pattern of Diabetes and Prediabetes in China in 2013.
Limin Wang, Pei Gao, Mei Zhang, Zhengjing Huang, Dudan Zhang, Qian Deng, Yichong Li, Zhenping Zhao, Xueying Qin, Danyao Jin,[...]. JAMA 2017
761
25

Improved Postprandial Glucose with Inhaled Technosphere Insulin Compared with Insulin Aspart in Patients with Type 1 Diabetes on Multiple Daily Injections: The STAT Study.
Halis Kaan Akturk, Janet K Snell-Bergeon, Amanda Rewers, Leslie J Klaff, Bruce W Bode, Anne L Peters, Timothy S Bailey, Satish K Garg. Diabetes Technol Ther 2018
19
25

Comparative assessment of the efficacy and safety of acarbose and metformin combined with premixed insulin in patients with type 2 diabetes mellitus.
Honghua Wu, Jie Liu, Qingqing Lou, Jing Liu, Li Shen, Mingxia Zhang, Xiaofeng Lv, Mingjun Gu, Xiaohui Guo. Medicine (Baltimore) 2017
6
25

Weight beneficial treatments for type 2 diabetes.
L F Meneghini, D Orozco-Beltran, K Khunti, S Caputo, T Damçi, A Liebl, S A Ross. J Clin Endocrinol Metab 2011
62
25

10-year follow-up of intensive glucose control in type 2 diabetes.
Rury R Holman, Sanjoy K Paul, M Angelyn Bethel, David R Matthews, H Andrew W Neil. N Engl J Med 2008
25

Glucose variability, blood pressure and arterial stiffness in type 1 diabetes.
D Gordin, M Rönnback, C Forsblom, V Mäkinen, M Saraheimo, P-H Groop. Diabetes Res Clin Pract 2008
31
25

MARCH2: comparative assessment of therapeutic effects of acarbose and metformin in newly diagnosed type 2 diabetes patients.
Guang Wang, Jia Liu, Ning Yang, Xia Gao, Hui Fan, Yuan Xu, Wenying Yang. PLoS One 2014
15
25


Novel glucose-sensing technology and hypoglycaemia in type 1 diabetes: a multicentre, non-masked, randomised controlled trial.
Jan Bolinder, Ramiro Antuna, Petronella Geelhoed-Duijvestijn, Jens Kröger, Raimund Weitgasser. Lancet 2016
366
25


Use of Flash Glucose-Sensing Technology for 12 months as a Replacement for Blood Glucose Monitoring in Insulin-treated Type 2 Diabetes.
Thomas Haak, Hélène Hanaire, Ramzi Ajjan, Norbert Hermanns, Jean-Pierre Riveline, Gerry Rayman. Diabetes Ther 2017
70
25




Lifetime Duration of Depressive Disorders in Patients With Type 2 Diabetes.
Mary de Groot, Kent A Crick, Molly Long, Chandan Saha, Jay H Shubrook. Diabetes Care 2016
18
25


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.